Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Fedor Moiseenko"'
Publikováno v:
Современная онкология, Vol 23, Iss 2, Pp 287-291 (2021)
Extensive-stage small cell lung cancer (ES-SCLC) is characterized by an aggressive course, a high recurrence rate and fast progression. For a long time, the survival prognosis for the most patients suffering from this disease remained unfavorable. Th
Autor:
Vitalii V. Egorenkov, Mikhail Y. Fedyanin, Andrey A. Bogdanov, Alexey A. Bogdanov, Fedor Moiseenko, Nikita M. Volkov
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 100-104 (2021)
The lack of trials directly comparing 2nd and 3rd generation EGFR tyrosine kinase inhibitors (TKI) do not allows to determine the optimal treatment approach. The main objective of this study was to compare the survival advantage achieved with these o